Research and development of Zika virus vaccines

npj Vaccines

Volumn 1, Issue , 2016, Pages

  Dawes, Brian E ^a   Smalley, Claire A ^a   Tiner, Bethany L ^a   Beasley, David W C ^a,b   Milligan, Gregg N ^a,b   Reece, Lisa M ^a,b   Hombach, Joachim ^c   Barrett, Alan D T ^a,b  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^c WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85015806084     PISSN: None     EISSN: 20590105     Source Type: Journal    
DOI: 10.1038/npjvaccines.2016.7     Document Type: Review

References (93)

1. Dick, G. W. A., Kitchen, S. F. &Haddow, A. J. Zika Virus (I). Isolations and serological specificity. Trans. R Soc. Trop. Med. Hyg. 46, 509-520 (1952).
2. Tognarelli, J. et al. A report on the outbreak of Zika virus on Easter Island, South Pacific, 2014. Arch. Virol. 161, 665-668 (2015).
3. Wong, P.-S. J., Li, M. I., Chong, C.-S., Ng, L.-C. &Tan, C.-H. Aedes (Stegomyia) albopictus (Skuse): a potential vector of Zika virus in Singapore. PLoS Negl. Trop. Dis. 7, e2348 (2013).
4. Dick, G. W. Zika virus (II). Pathogenicity and physical properties. Trans. R. Soc. Trop. Med. Hyg. 46, 521-534 (1952).
5. Kelser, E. A. Meet dengue's cousin, Zika. Microbes Infect. 18, 163-166 (2015).
6. Faye, O. et al. Molecular evolution of Zika virus during its emergence in the 20th century. PLoS Negl. Trop. Dis. 8, e2636 (2014).
7. Haddow, A. D. et al. Genetic characterization of Zika virus strains: geographic expansion of the Asian lineage. PLoS Negl. Trop. Dis. 6, e1477 (2012).
8. Lanciotti, R. S., Lambert, A. J., Holodniy, M., Saavedra, S. &del Carmen Castillo Signor, L. Phylogeny of Zika Virus in Western Hemisphere, 2015. Emerg. Infect. Dis. 22, 933-935 (2016).
9. Fauci, A. S. &Morens, D. M. Zika virus in the Americas-yet another arbovirus threat. N. Engl. J. Med. 374, 601-604 (2016).
10. Craig, A. T., Butler, M. T., Pastmore, R., Paterson, B. J. &Durrheim, D. N. Update on Zika virus transmission in the Pacific islands, 2007 to February 2016 and failure of acute flaccid paralysis surveillance to signal Zika emergence in this setting. Bull. World Health Organ; epub ahead of print 19 February 2016, doi: http://dx.doi.org/ 10.2471/BLT.16.1711892 (2016).
11. Faria, N. R. et al. Zika virus in the Americas: early epidemiological and genetic findings. Science 352, 345-349 (2016).
12. Grard, G. et al. Zika Virus in Gabon (Central Africa)-2007: a new threat from Aedes albopictus? PLoS Negl. Trop. Dis. 8, e2681 (2014).
13. Duffy, M. R. et al. Zika virus outbreak on Yap Island, Federated States of Micronesia. N. Engl. J. Med. 360, 2536-2543 (2009).
14. Leroy, E. M. et al. Concurrent chikungunya and dengue virus infections during simultaneous outbreaks, Gabon, 2007. Emerg. Infect. Dis. 15, 591-593 (2009).
15. Cao-Lormeau, V.-M. et al. Zika virus, French Polynesia, South Pacific, 2013. Emerg. Infect. Dis. 20, 1084-1086 (2014).
16. Tappe, D. et al. Cytokine kinetics of Zika virus-infected patients from acute to reconvalescent phase. Med. Microbiol. Immunol. (Berl.) 205, 269-273 (2015).
17. Gourinat, A.-C., O'Connor, O., Calvez, E., Goarant, C. &Dupont-Rouzeyrol, M. Detection of Zika virus in Urine. Emerg. Infect. Dis. 21, 84-86 (2015).
18. Schwan, K. Zika Virus-Pacific (07): chile (Easter Island), French Polynesia (International Society for Infectious Diseases, 2014).
19. Zanluca, C. et al. First report of autochthonous transmission of Zika virus in Brazil. Mem. Inst. Oswaldo Cruz 110, 569-572 (2015).
20. World Health Organization. Zika Virus, Microcephaly and Guillain-Barré Syndrome. Situation Report 1-13 (2016). http://apps.who.int/iris/bitstream/10665/204690/1/ zikasitrep24Mar2016eng.pdf?ua=1 (28 April 2016).
21. Buathong, R. et al. Detection of Zika virus infection in Thailand, 2012-2014. Am. J. Trop. Med. Hyg. 93, 380-383 (2015).
22. Alera, M. T. et al. Zika virus infection, Philippines, 2012. Emerg. Infect. Dis. 21, 722-724 (2015).
23. Calvet, G. A. et al. First detection of autochthonous Zika virus transmission in a HIV-infected patient in Rio de Janeiro, Brazil. J. Clin. Virol. 74, 1-3 (2016).
24. Enfissi, A., Codrington, J., Roosblad, J., Kazanji, M. &Rousset, D. Zika virus genome from the Americas. Lancet 387, 227-228 (2016).
25. Lednicky, J. et al. Zika virus outbreak in Haiti in 2014: molecular and clinical data. PLoS Negl. Trop. Dis. 10, e0004687 (2016).
26. Zhu, Z. et al. Comparative genomic analysis of pre-epidemic and epidemic Zika virus strains for virological factors potentially associated with the rapidly expanding epidemic. Emerg. Microbes Infect. 5, e22 (2016).
27. Weinbren, M. &Williams, M. Zika virus: further isolations in the zika area, and some studies on the strains isolated. Trans. R. Soc. Trop. Med. Hyg. 52, 263-268 (1958).
28. Musso, D. et al. Potential for Zika virus transmission through blood transfusion demonstrated during an outbreak in French Polynesia, November 2013 to February 2014. Eurosurveillance 19, 20761 (2014).
29. Darwish, M. A., Hoogstraal, H., Roberts, T. J., Ahmed, I. P. &Omar, F. A seroepidemiological survey for certain arboviruses (Togaviridae) in Pakistan. Trans. R. Soc. Trop. Med. Hyg. 77, 442-445 (1983).
30. Henderson, B. E., Hewitt, L. E. &Lule, M. Serology of Wild Mammals 48-51 (East African Printer, 1968).
31. Malone, R. W. et al. Zika virus: medical countermeasure development challenges. PLoS Negl. Trop. Dis. 10, e0004530 (2016).
32. Higgs, S. Zika virus: emergence and emergency. Vector-Borne Zoonotic Dis. 16, 75-76 (2016).
33. Besnard, M., Teissier, S., Cao-Lormeau, V. &Musso, D. Evidence of perinatal transmission of Zika virus, French Polynesia, December 2013 and February 2014. Euro Surveill. 19, 1-4 (2014).
34. Ayres, C. F. J. Identification of Zika virus vectors and implications for control. Lancet Infect. Dis. 16, 278-279 (2016).
35. Deckard, D. T. et al. Male-to-male sexual transmission of Zika virus-Texas. January 2016. MMWR Morb. Mortal. Wkly. Rep. 65, 372-374 (2016).
36. McCarthy, M. Zika cases climb to 147 in US and Puerto Rico. BMJ 352, i1212 (2016).
37. Wolfe, M. S., Calisher, C. H. &McGuire, K. Spondweni virus infection in a foreign resident of Upper Volta. Lancet 320, 1306-1308 (1982).
38. European Centre for Disease Prevention and Control (ECDC). Zika Virus Disease Epidemic: Potential Association with Microcephaly and Guillain-Barre Syndrome. First Update, 21 January 2016 (ECDC, Stockholm, 2016).
39. Rossi, S. L. et al. Characterization of a novel murine model to study Zika virus. Am. J. Trop. Med. Hyg. 94, 1362-1369 (2016).
40. Schwartz, O. &Albert, M. L. Biology and pathogenesis of chikungunya virus. Nat. Rev. Microbiol. 8, 491-500 (2010).
41. Paixão, E. S. et al. History, epidemiology, and clinical manifestations of zika: a systematic review. Am. J. Public Health 106, 606-612 (2016).
42. Focosi, D., Maggi, F. &Pistello, M. Zika virus implications for public health. Clin. Infect. Dis. ciw210, 1-7 (2016).
43. Martines, R. B. Evidence of Zika virus infection in brain and placental tissues form two congenitally infected newborns and two fetal losses-Brazil, 2015. MMWR 65 159-160 (2016).
44. Heymann, D. L. et al. Zika virus and microcephaly: why is this situation a PHEIC? Lancet 387, 719-721 (2016).
45. Ventura, C. V., Maia, M., Bravo-Filho, V., Góis, A. L. &Belfort, R. Zika virus in Brazil and macular atrophy in a child with microcephaly. Lancet 387, 228 (2016).
46. Miranda-Filho, D. et al. Initial description of the presumed congenital Zika syndrome. Am. J. Public Health 106, 598-600 (2016).
47. Schuler-Faccini, L. et al. Possible association between Zika virus infection and microcephaly-Brazil, 2015. MMWR Morb. Mortal. Wkly. Rep. 65, 59-62 (2016).
48. Cauchemez, S. et al. Association between Zika virus and microcephaly in French Polynesia, 2013-15: a retrospective study. Lancet 387, 2125-2132 (2016).
49. Basarab, M., Bowman, C., Aarons, E. J. &Cropley, I. Zika virus. BMJ 352, i1049 (2016).
50. Centers for Disease Control and Prevention (CDC). CDC concludes zika causes microcephaly and other birth defects. Media Statement, Wednesday, 13 April 2016. http://www.cdc.gov/media/releases/2016/s0413-zika-microcephaly.html (16 April 2016).
51. Rasmussen, S. A., Jamieson, D. J., Honein, M. A. &Petersen, L. R. Zika virus and birth defects-reviewing the evidence for causality. N. Engl. J. Med. 374, 1981-1987 (2016).
52. Malkki, H. CNS infections: Zika virus infection could trigger Guillain-Barré syndrome. Nat. Rev. Neurol. 12, 187-187 (2016).
53. European Centre for Disease Prevention and Control (ECDC). Zika Virus Disease Epidemic: Potential Association with Microcephaly and Guillain-Barre Syndrome. Fourth update, 9 March 2016 (ECDC, Stockholm, 2016).
54. Rozé, B. et al. Zika virus detection in urine from patients with Guillain-Barré synbdrome on Martinique, January 2016. Euro Surveill 21 (2016). doi: http://dx. doi.org/10.28707/1560-7917.ES.2016.21.9.30154.
55. Hughes, S. Zika Virus Now Linkeed to Autoimmune Neurologic Conditions (Medscape, 2016).
56. Lucchese, G. &Kanduc, D. Zika virus and autoimmunity: from microcephaly to Guillain-Barré syndrome, and beyond. Autoimmun. Rev. 15, 801-808 (2016).
57. Anaya, J.-M. et al. Zika virus and neurologic autoimmunity: the putative role of gangliosides. BMC Med. 14, 49 (2016).
58. Ricketson, R. &Weiler, L. J. Zika virus induced neurotropic brain injury: lessons for the study of disease etiology and vaccine development against pathogens. WebmedCentral Virol. 7, WMC005082 (2016).
59. Araujo, L. M., Ferreira, M. L. B. &Nascimento, O. J. Guillain-Barré syndrome associated with the Zika virus outbreak in Brazil. Arq. Neuropsiquiatr. 74, 253-255 (2016).
60. Musso, D. et al. Detection of Zika virus in saliva. J. Clin. Virol. 68, 53-55 (2015).
61. Fonseca, K. et al. First case of Zika virus infection in a returning Canadian traveler. Am. J. Trop. Med. Hyg. 91, 1035-1038 (2014).
62. Lanciotti, R. S. et al. Genetic and serologic properties of Zika virus associated with an epidemic, Yap State, Micronesia, 2007. Emerg. Infect. Dis. 14, 1232-1239 (2008).
63. Centers for Disease Control and Prevention, Division of Vector-Borne Diseases. Memorandum: Updated diagnostic testing for Zika, chikungunya, and dengue viruses in US Public Health Laboratories (2016). http://www.cdc.gov/zika/pdfs/ denvechikzvikv-testing-algorithm.pdf (20 April 2016).
64. Saxena, S. K., Elahi, A., Gadugu, S. &Prasad, A. K. Zika virus outbreak: an overview of the experimental therapeutics and treatment. VirusDis. 27, 111-115 (2016).
65. Vannice, K. S., Roehrig, J. T. &Hombach, J. Next generation dengue vaccines: a review of the preclinical development pipeline. Vaccine 33, 7091-7099 (2015).
66. Olson, J. G., Ksiazek, T. G., Suhandiman &Triwibowo. Zika virus, a cause of fever in Central Java, Indonesia. Trans. R. Soc. Trop. Med. Hyg. 75, 389-393 (1981).
67. Plotkin, S. A. Correlates of protection induced by vaccination. Clin. Vaccine Immunol. 17, 1055-1065 (2010).
68. Barrett, A. D. T. in Vaccinology: An Essential Guide (eds Milligan, G. &Barrett, A. D. T.) 175-176 (John Wiley and Sons, Inc, 2015).
69. Ulmer, J. B., Valley, U. &Rappuoli, R. Vaccine manufacturing: challenges and solutions. Nat. Biotechnol. 24, 1377-1383 (2006).
70. Guy, B., Saville, M. &Lang, J. Development of sanofi pasteur tetravalent dengue vaccine. Hum. Vaccine 6, 696-705 (2010).
71. Halstead, S. B. &Thomas, S. J. New Japanese encephalitis vaccines: alternatives to production in mouse brain. Expert Rev. Vaccines 10, 355-364 (2011).
72. Chokephaibulkit, K. et al. Safety and immunogenicity of a single administration of live-attenuated Japanese encephalitis vaccine in previously primed 2-to 5-yearolds and naive 12-to 24-month-olds: multicenter randomized controlled trial. Pediatr. Infect. Dis. J. 29, 1111-1117 (2010).
73. Kasabi, G. S. et al. Coverage and effectiveness of Kyasanur forest disease (KFD) vaccine in Karnataka, South India, 2005-10. PLoS Negl. Trop. Dis. 7, e2025 (2013).
74. Holbrook, M. R. Kyasanur forest disease. Antiviral Res. 96, 353-362 (2012).
75. Kostyuchenko, V. A. et al. Structure of the thermally stable Zika virus. Nature 533, 425-428 (2016).
76. Sirohi, D. et al. The 3.8 Å resolution cryo-EM structure of Zika virus. Science 352, 467-470 (2016).
77. Dai, L. et al. Structures of the Zika virus envelope protein and its complex with a flavivirus broadly protective antibody. Cell Host Microbe 19, 696-704 (2016).
78. Song, H., Qi, J., Haywood, J., Shi, Y. &Gao, G. F. Zika virus NS1 structure reveals diversity of electrostatic surfaces among flaviviruses. Nat. Struct. Mol. Biol. 23, 456-458 (2016).
79. Yauch, L. E. &Shresta, S. in Advances in Virus Research Vol. 88, 315-372 (Elsevier, 2014).
80. Porter, K. R. &Raviprakash, K. Nucleic acid (DNA) immunization as a platform for dengue vaccine development. Vaccine 33, 7135-7140 (2015).
81. Meier, K. C., Gardner, C. L., Khoretonenko, M. V., Klimstra, W. B. &Ryman, K. D. A mouse model for studying viscerotropic disease caused by yellow fever virus infection. PLoS Pathog. 5, e1000614 (2009).
82. Shresta, S., Sharar, K. L., Prigozhin, D. M., Beatty, P. R. &Harris, E. Murine model for dengue virus-induced lethal disease with increased vascular permeability. J. Virol. 80, 10208-10217 (2006).
83. Sarathy, V. V., Milligan, G. N., Bourne, N. &Barrett, A. D. T. Mouse models of dengue virus infection for vaccine testing. Vaccine 33, 7051-7060 (2015).
84. Milligan, G. N. et al. A dengue virus type 4 model of disseminated lethal infection in AG129 mice. PLoS ONE 10, e0125476 (2015).
85. Dowall, S. D. et al. A susceptible mouse model for Zika virus infection. PLoS Negl. Trop. Dis. 10, e0004658 (2016).
86. Lazear, H. M. et al. A mouse model of Zika virus pathogenesis. Cell Host Microbe 19, 720-730 (2016).
87. Zmurko, J. et al. The viral polymerase inhibitor 7-deaza-2'-C-methyladenosine is a potent inhibitor of in vitro Zika virus replication and delays disease progression in a robust mouse infection model. PLoS Negl. Trop. Dis. 10, e0004695 (2016).
88. Aliota, M. T. et al. Characterization of lethal Zika virus infection in AG129 mice. PLoS Negl. Trop. Dis. 10, e0004682 (2016).
89. Dudley, D. M. et al. A rhesus macaque model of Asian-lineage Zika virus infection. Nat Commun. 7, 12204 (2016).
90. Cumming-Bruce, N. Zika vaccine still years away, W.H.O. says. The New York Times 9 March 2016. www.nytimes.com/2016/03/10/world/americas/zika-vaccine-still-years-away-who-says.html?r=0 (4 May 2016).
91. Maurice, J. WHO reveals its shopping list for weapons against Zika. Lancet 387, 733 (2016).
92. Larocca, R. A. et al. Vaccine protection against Zika virus from Brazil. Nature doi:10.1038/nature18952.
93. Schwartz, L. M., Halloran, M. E., Durbin, A. P. &Longini, I. M. The dengue vaccine pipeline: implications for the future of dengue control. Vaccine 33, 3293-3298 (2015).